Spring Bank Pharmaceuticals, Inc. 4

4 · Spring Bank Pharmaceuticals, Inc. · Filed Sep 12, 2016

Insider Transaction Report

Form 4
Period: 2016-09-09
Afdhal Nezam H.
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2016-09-09$12.50/sh+2,400$30,00040,150 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION